These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 31385775

  • 1. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques.
    Abdizadeh R, Hadizadeh F, Abdizadeh T.
    Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775
    [Abstract] [Full Text] [Related]

  • 2. QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations Studies of Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Anticancer Agents.
    Abdizadeh R, Heidarian E, Hadizadeh F, Abdizadeh T.
    Anticancer Agents Med Chem; 2021; 21(8):987-1018. PubMed ID: 32698753
    [Abstract] [Full Text] [Related]

  • 3. CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors.
    Jiang YR, Yang YY, Chen YL, Liang ZJ.
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):385-95. PubMed ID: 24010934
    [Abstract] [Full Text] [Related]

  • 4. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
    Chhatbar DM, Chaube UJ, Vyas VK, Bhatt HG.
    Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
    [Abstract] [Full Text] [Related]

  • 5. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
    Gajjar KA, Gajjar AK.
    Curr Drug Discov Technol; 2020 Jun; 17(1):100-118. PubMed ID: 30160214
    [Abstract] [Full Text] [Related]

  • 6. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A, Hu J, Wang L, Zhong G, Pan J, Wu Z, Hui A.
    J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
    [Abstract] [Full Text] [Related]

  • 7. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.
    Zhang S, Hou B, Yang H, Zuo Z.
    Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327
    [Abstract] [Full Text] [Related]

  • 8. Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer's disease.
    El Khatabi K, El-Mernissi R, Aanouz I, Ajana MA, Lakhlifi T, Khan A, Wei DQ, Bouachrine M.
    J Mol Model; 2021 Sep 28; 27(10):302. PubMed ID: 34581863
    [Abstract] [Full Text] [Related]

  • 9. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB, Aguan K, Mitra S, Bhattacharjee A.
    J Biomol Struct Dyn; 2017 Jun 28; 35(8):1729-1742. PubMed ID: 27410776
    [Abstract] [Full Text] [Related]

  • 10. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
    Akula N, Lecanu L, Greeson J, Papadopoulos V.
    Bioorg Med Chem Lett; 2006 Dec 15; 16(24):6277-80. PubMed ID: 17049234
    [Abstract] [Full Text] [Related]

  • 11. Computational Prediction of 3,5-Diaryl-1H-Pyrazole and spiropyrazolines derivatives as potential acetylcholinesterase inhibitors for alzheimer disease treatment by 3D-QSAR, molecular docking, molecular dynamics simulation, and ADME-Tox.
    El Alaouy MA, Alaqarbeh M, Ouabane M, Zaki H, ElBouhi M, Badaoui H, Moukhliss Y, Sbai A, Maghat H, Lakhlifi T, Bouachrine M.
    J Biomol Struct Dyn; 2024 Nov 15; 42(18):9547-9560. PubMed ID: 37655700
    [Abstract] [Full Text] [Related]

  • 12. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis.
    Roy KK, Dixit A, Saxena AK.
    J Mol Graph Model; 2008 Sep 15; 27(2):197-208. PubMed ID: 18515163
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 2D & 3D-QSAR Study on Novel Piperidine and Piperazine Derivatives as Acetylcholinesterase Enzyme Inhibitors.
    Nazari M, Tabatabai SA, Rezaee E.
    Curr Comput Aided Drug Des; 2018 Sep 15; 14(4):391-397. PubMed ID: 30047333
    [Abstract] [Full Text] [Related]

  • 16. Receptor-based modeling and 3D-QSAR for a quantitative production of the butyrylcholinesterase inhibitors based on genetic algorithm.
    Zaheer-ul H, Uddin R, Yuan H, Petukhov PA, Choudhary MI, Madura JD.
    J Chem Inf Model; 2008 May 15; 48(5):1092-103. PubMed ID: 18444627
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cholesteryl ester transfer protein inhibitors in coronary heart disease: Validated comparative QSAR modeling of N, N-disubstituted trifluoro-3-amino-2-propanols.
    Mondal C, Halder AK, Adhikari N, Jha T.
    Comput Biol Med; 2013 Oct 15; 43(10):1545-55. PubMed ID: 24034746
    [Abstract] [Full Text] [Related]

  • 19. Pharmacophore based 3DQSAR of phenothiazines as specific human butyrylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Kundaikar HS, Agre NP, Degani MS.
    Curr Comput Aided Drug Des; 2014 Oct 15; 10(4):335-48. PubMed ID: 25794302
    [Abstract] [Full Text] [Related]

  • 20. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
    Daoud I, Melkemi N, Salah T, Ghalem S.
    Comput Biol Chem; 2018 Jun 15; 74():304-326. PubMed ID: 29747032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.